SK Biopharmaceutical’s Epilepsy Drug Xcopri Now Available in South Korea, Cutting Monthly Medication Costs by Up to $200
Xcopri (generic name: cenobamate), an epilepsy drug developed by SK Biopharmaceutical, has completed its initial domestic shipment and is now available for prescription in South Korea. Korean patients who previously obtained the medication in the Uni